The cyclic AMP pathway is a sex-specific modifier of glioma risk in type 1 neurofibromatosis patients

Identifying modifiers of glioma risk in patients with type 1 neurofibromatosis (NF1) could help support personalized tumor surveillance, advance understanding of gliomagenesis and potentially identify novel therapeutic targets. Here we report genetic polymorphisms in the human adenylate cyclase gene...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res
Main Authors: Warrington, Nicole M., Sun, Tao, Luo, Jingqin, McKinstry, Robert C., Parkin, Patricia C., Ganzhorn, Sara, Spoljaric, Debra, Albers, Anne C., Merkelson, Amanda, Stewart, Douglas R., Stevenson, David A., Viskochil, David, Druley, Todd E., Forys, Jason T, Reilly, Karlyne M., Fisher, Michael J., Tabori, Uri, Allen, Jeffrey C., Schiffman, Joshua D., Gutmann, David H., Rubin, Joshua B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4286430/
https://ncbi.nlm.nih.gov/pubmed/25381154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-14-1891
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados